Related Experiment Videos
[Progress in hypocholesterolemic therapy in the prevention of recurrent infarction]
E Manzato1, S Zambon, G Crepaldi
1Istituto di Medicina Interna, Università degli Studi di Padova.
Insights
Lowering cholesterol after myocardial infarction significantly reduces reinfarction and mortality. Achieving total cholesterol below 200 mg/dL, or LDL cholesterol below 100 mg/dL, is crucial for secondary prevention.
Area of Science:
- Cardiology
- Vascular Biology
- Preventive Medicine
Background:
- Hypercholesterolemia is a significant risk factor for recurrent vascular events after myocardial infarction.
- While infarct size impacts survival, managing cholesterol is key for secondary prevention.
- Atherosclerotic plaques, particularly unstable ones, drive clinical events post-myocardial infarction.
Purpose of the Study:
- To evaluate the role of hypocholesterolemic therapy in preventing reinfarction.
- To assess the impact of cholesterol reduction on clinical outcomes and mortality in post-myocardial infarction patients.
Main Methods:
- Analysis of data from observational studies.
- Review of secondary prevention trials.
- Evaluation of cholesterol levels (total and LDL) and their correlation with clinical events.
Main Results:
- Cholesterol reduction to < 200 mg/dL total or < 100 mg/dL LDL is associated with significant decreases in clinical events and mortality within years.
- Clinical event reduction occurs rapidly, suggesting prompt plaque modification.
- Drug therapy is effective in achieving target cholesterol levels post-myocardial infarction.
Conclusions:
- Hypocholesterolemic therapy is beneficial for reinfarction prevention after myocardial infarction.
- Aggressive cholesterol lowering can rapidly modify atherosclerotic plaque behavior.
- Achieving specific cholesterol targets (< 200 mg/dL total, < 100 mg/dL LDL) is recommended, potentially with pharmacologic support.
Abstract:
The role of the hypocholesterolemic therapy in reinfarction prevention is evaluated using data from observational and secondary prevention studies. Even though survival after myocardial infarction is largely determined by the extension of the necrotic lesion, hypercholesterolemia remains an important risk factor for new vascular events. A total cholesterol reduction < 200 mg/dL (or even better LDL cholesterol < 100 mg/dL) in these patients is associated within few years with a significant reduction of both clinical events and total mortality. The reduction of clinical events is obtained in a relatively short period of time thus suggesting that plasma cholesterol reduction induces quite rapidly some modifications of the natural history of the atherosclerotic plaques, this effect being more relevant in vulnerable or unstable lesions that are responsible for most of the clinical events. These observations show that after myocardial infarction it is useful to reduce cholesterol < 200 mg/dL also with the use of drugs.